Related Experiment Video

Updated: Mar 17, 2026

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K

Gastric Cancer: Nanoparticles as Tools to Improve Treatment Efficacy

Ariel R Guerrero, Felipe Oyarzun-Ampuero1, Natalia Hassan

  • 1Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile. Santos Dumont 964, Independencia, Santiago, Chile.

Current Pharmaceutical Design
|July 15, 2016
PubMed

Insights

Nanotechnology offers new hope for treating gastric cancer, a leading cause of cancer deaths. This review explores nanoparticle-based strategies to improve drug targeting and reduce side effects for better gastric cancer treatment.

Area of Science:

  • Oncology
  • Nanotechnology
  • Materials Science

Background:

  • Gastric cancer is a significant global health challenge, responsible for numerous cancer-related deaths worldwide.
  • Current treatment options for gastric cancer have limitations, necessitating the exploration of novel therapeutic approaches.

Purpose of the Study:

  • To review recent advances in nanotechnology for gastric cancer treatment.
  • To discuss various nanoparticle systems being investigated for improved drug delivery and reduced toxicity.

Main Methods:

  • Review of current literature on nanotechnology applications in gastric cancer therapy.
  • Analysis of polymeric nanosystems, nanovesicular systems, and inorganic nanoparticles for drug delivery.

Main Results:

  • Nanoparticle-based strategies show promise in enhancing the targeted delivery of anticancer drugs.
  • These advanced systems have the potential to minimize adverse side effects associated with conventional chemotherapy.

Conclusions:

  • Nanotechnology presents a promising frontier for developing more effective and safer treatments for gastric cancer.
  • Further research into nanoparticle-based systems could revolutionize gastric cancer therapy.

More Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.6K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

8.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
723